BuzzSparks.org

Celator Pharmaceuticals


Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1...

Homepage:
Total money raised: $66M

08540 303B College Road East

Princeton
USA NJ

Phone: (609) 243-0123

Updated on Sep 12, 2013
Celator Pharmaceuticals at CrunchBase
Scott Jackson CEO
Nicole Vitullo Board Member
Past
Eric Heil Senior Director, Business Development

April, 2013

Celator Pharmaceuticals raised $39.3M in private_equity round from ROTH Capital Partners and Valence Life Sciences

CELATOR® PHARMACEUTICALS RAISES $32.5 MILLION COMPLETING A $39.3 MILLION PRIVATE PLACEMENT FINANCING    celatorpharma.com

December, 2012

Celator Pharmaceuticals raised $2.6M in partial round

SEC    sec.gov

August, 2012

Celator Pharmaceuticals raised $4.1M in partial round

SEC    sec.gov

September, 2010

Celator Pharmaceuticals raised $20M in a Series D round from Thomas, McNerney & Partners, Domain Associates, Ventures West, Quaker BioVentures, TL Ventures, GrowthWorks Capital, and BDC Venture Capital

CELATOR® PHARMACEUTICALS RAISES $20 MILLION IN SERIES D FINANCING    celatorpharma.com